GTC Taiwan—NVIDIA today introduced NVIDIA HGX-2, the first unified computing platform for both artificial intelligence and high performance computing.

We can’t all be starship captains. But visitors to Planetarium No. 1 in St. Petersburg, Russia, can experience the universe with a level of clarity, detail and interactivity that Captain Kirk himself would envy. Housed in a 19th century natural gas ...

Ever since a Dutch cloth merchant accidentally discovered bacteria in 1676, microscopes have been a critical tool for medicine. Today’s microscopes are 800,000 times more powerful than the human eye, but they still need a person to scrutinize what’s ...

NVIDIA will present at the following events for the financial community:

Automotive safety isn’t a box you check. It’s not a feature. Safety is the whole point of autonomous vehicles. And it starts with a new class of computer, a new type of software and a new breed of chips. Safety is designed into the NVIDIA DRIVE ...

Get up. Brush your teeth. Put on your pants. Go to the office. That’s reality. Now, imagine you can play Tony Stark in Iron Man or the Joker in Batman. That’s virtual reality. Advances in VR have enabled people to create, play, work, collaborate and ...

It’s no wonder Dr. Elliot Fishman sounds frustrated when he talks about pancreatic cancer. As a diagnostic radiologist at Johns Hopkins Hospital, one of the world’s largest centers for pancreatic cancer treatment, he has the grim task of examining ...

We’re bringing NVIDIA researchers — the brains behind our bots — to the International Conference on Robotics and Automation (ICRA) in Brisbane, Australia, from May 21-25. And they want to meet you. Held annually since 1984, ICRA has become a premier ...

Gravitational lenses have long been one of astronomy’s white whales, perplexing those who have devoted themselves to finding and studying them. But by applying deep learning and computer vision to the abundant data generated by today’s powerful ...

An aging population. Antibiotic-resistant infections. Afflictions by the hundreds that still lack a cure. The need for new medications is higher than ever, but so is the cost and time to bring them to market. Developing a new drug can cost billions ...